AstraZeneca reported 884.69B in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Alcon AG ALC:SW 2.12B 71.99M
Amgen AMGN:US $ 6594M 356M
Artemis Alpha ATS:LN -2586300000 1.65B
Astrazeneca AZN:US $ 10771M 619M
AstraZeneca AZN:SS SK 10771M 619M
AstraZeneca AZN:LN 884686.86M 17406.7M
Bayer BAYN:GR € 12819M 1820M
Biogen BIIB:US $ 2589.1M 57.3M
Bristol Myers Squibb BMY:US $ 11887M 239M
Eli Lilly And LLY:US $ 6488M 1322M
Fresenius FRE:GR € 10018M 298M
Fresenius Medical Care FME:GR € 4757M 208.63M
Galapagos GLPG:NA € 147.57M 3.54M
Genmab GEN:DC DK 3162M 1043M
Gilead Sciences GILD:US $ 6260M 330M
GlaxoSmithKline GSK:LN 692900M 26100M
Hikma Pharmaceutical HIK:LN 99.63B 806.61M
Lonza Group LONN:SW 2.98B 115M
Merck MRK:GR € 5568M 370M
Merk MRK:US $ 14593M 1308M
Novartis NOVN:VX SF 13085M 271M
Orion ORNBV:FH € 283.7M 13.1M
Pfizer PFE:US $ 27742M 2081M
Philips PHIA:NA € 4177M 259M
Recordati REC:IM € 473.11M 53.73M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Roche Holding ROG:VX 16.44B 474M